Novel polypeptide composition for intracellular transfection
AssigneeAzothbio Inc.
InventorsJae Min Shin, Jung-Hyun Park, Ji Yeon Chang, Song Mi Kim, Meriem Bouchane
Life of this patent
Estimating the term…
Abstract
The present disclosure pertains to: a novel polypeptide composition for intracellular transfection; and uses thereof. This novel polypeptide composition for intracellular transfection has the advantage of greatly improving the transfection efficacy of target substances and having remarkably low cytotoxicity. Accordingly, the polypeptide composition has a variety of uses since various substances can be transported into cells thereby.
Claims29
A polypeptide comprising:
- 9, 10, or 11 consecutive leucines (Leu);
- and 1, 2, 3, or 4 repeats of peptide of SEQ ID NO:
- 1 linked thereto.
A composition for intracellular transfection, comprising:
- a polypeptide comprising 9, 10, or 11 consecutive leucines (Leu) and 1, 2, 3, or 4 repeats of peptide of SEQ ID NO:
- 1 linked thereto;
- and
- a target substance.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for delivering a target substance into a cell, comprising:
- contacting the cell with a composition for intracellular transfection, comprising a polypeptide comprising 9, 10, or 11 consecutive leucines (Leu) and 1, 2, 3, or 4 repeats of peptide of SEQ ID NO:
- 1 linked thereto;
- and a target substance.
Dependencies are inferred from the claim text.